Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM1W5G9)

Drug Name

GPCR39 pepducins Drug Info

Synonyms

GPCR39 pepducins (lipopeptide, diabetes/obesity); GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor Therapeutics; GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor/Janssen; G-protein coupled receptor-39 modulators (lipopeptide, diabetes/obesity), Anchor Therapeutics; GPCR39 pepducins (lipopeptide, diabetes/obesity), Anchor Therapeutics/ Ortho-McNeil-Janssen

Indication

Disease Entry	ICD 11	Status	REF
Diabetic complication	5A2Y	Investigative	[1]

Cross-matching ID

TTD Drug ID: DM1W5G9

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting G-protein coupled receptor 39 (GPR39)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID24900608C1	DMCL6H3	Discovery agent	N.A.	Investigative	[2]
PMID25313322C15	DMDO9AJ	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
G-protein coupled receptor 39 (GPR39)	TTTPCNU	GPR39_HUMAN	Modulator	[1]

------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 105).
2	Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example. ACS Med Chem Lett. 2013 Sep 16;4(11):1079-84.
3	Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists. ACS Med Chem Lett. 2014 Aug 4;5(10):1114-8.